Cumberland Pharmaceuticals Inc. has acquired the U.S. rights to commercialize prescription laxative Kristalose, a move its CEO says will double revenue and raise the company's profile. Cumberland, ...
Good afternoon. And welcome to Cumberland Pharmaceuticals Second Quarter 2024 Financial Report and Company Update. This call is being recorded at the company's request and will be archived on its ...
Cumberland Pharmaceuticals (NASDAQ:CPIX) Inc. has announced a successful financial year with net revenues reaching $40 million in 2023. The company's key products, including Sancuso, Kristalose, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results